查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1722418

2025 年至 2033 年手术部位感染控制市场报告（按产品、感染类型、手术类型、最终用户和地区）

Surgical Site Infection Control Market Report by Product, Infection Type, Surgery Type, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球手术部位感染控制市场规模达 48 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 67 亿美元，2025-2033 年期间的成长率 (CAGR) 为 3.59%。外科手术的增加、对医疗相关感染的认识不断提高、对病人安全的关注度不断提高以及医疗支出的激增是推动市场成长的一些主要因素。

手术部位感染控制市场分析：

主要市场驱动因素：由于人口老化、久坐的生活方式和不健康的饮食习惯，医院内感染病例不断增加，癌症、胃肠道疾病、心血管疾病（CVD）等慢性病患病率不断上升，推动了手术部位感染控制的采用。此外，各国政府和非政府机构采取的多项有利倡议，例如引入严格的指导方针和以感染控制实践为重点的培训计划，正在推动手术部位感染控制市场的发展。

主要市场趋势：手术部位感染的日益普及、感染控制产品的技术不断进步、微创手术的日益普及以及严格监管标准的出台，预计将推动手术部位感染控制市场的需求。此外，随着全球医疗支出的增加，人们越来越关注改善病患治疗效果和减少医疗相关感染，包括手术部位感染 (SSI)。预计这一趋势将推动外科手术环境中对先进感染控制解决方案的需求。

竞争格局：一些领先的手术部位感染控制市场公司包括 3M 公司、安思尔有限公司、碧迪公司和 bioMerieux SA。 (梅里埃研究所)、Covalon Technologies Ltd.、GAMA Healthcare Ltd.、Getinge AB (Carl Bennet AB)、强生公司、金佰利公司、Molnlycke Health Care AB、Prescient Surgical 和 Steris Corporation 等。

地理趋势：根据报告，北美目前占据整个市场的主导地位。该地区是全球最大的手术部位感染控制产品和服务市场之一。市场规模受到外科手术数量的增加、先进的医疗基础设施、广泛的监管环境、持续的技术创新等因素的影响。由于人们对医疗相关感染和感染预防措施重要性的认识不断提高，市场一直经历稳定成长。

挑战与机会：抗生素抗药性、依从性问题、成本考量以及不同医疗机构的手术实践和方案的差异是市场面临的一些挑战。然而，医疗技术的进步，例如抗菌涂层、新型手术材料和机器人辅助手术的发展，为手术部位感染控制市场提供了加强手术环境中感染控制的最新机会。

手术部位感染控制市场趋势：

老年人口不断增加

全球许多地区正在经历人口结构变化，其特征是 65 岁及以上老年人口比例不断增加。例如，根据世界卫生组织的数据，到2030年，世界上每六个人中就有一人年龄在60岁或以上。届时，60岁以上人口比例将从2020年的10亿上升至14亿。到 2050 年，全球 60 岁及以上人口将翻倍（21 亿）。预计2020年至2050年间，80岁以上人口数将增加两倍，达4.26亿。由于与年龄相关的免疫系统变化、组织癒合能力下降以及糖尿病、高血压和心血管疾病等合併症的存在，老年人更容易受到 SSI 的侵害。随着老年人口的增长，老年人接受手术的数量也相应增加，对降低手术部位感染风险的感染控制措施的需求也随之增加。例如，根据美国国家医学图书馆 2021 年 3 月发表的一篇文章，65 岁及以上的老年人每年进行近 400 万次外科手术。与此一致，根据美国国家医学图书馆 2023 年 3 月发表的另一篇文章，在全膝关节置换手术中，76-80 岁年龄组的老年人的 SSI 发生率高于 61-65 岁年龄组。这些因素进一步增强了手术部位感染市场的收入。

增加外科手术和医疗保健基础设施发展

世界各地的外科手术数量显着增加。例如，根据美国国家医学图书馆发表的一篇文章，2020 年 9 月，全球 11% 的疾病负担需要手术介入、麻醉管理或两者兼而有之。最常见的手术是白内障（22.8%）、剖腹产（3.8%）、骨折手术（3.27%）和疝气（2.86%）。必要手术占所有手术的44.2％。此外，医疗保健基础设施发展计划（尤其是在新兴市场）促进了手术部位感染控制市场的成长。根据印度投资网发表的一篇文章，到 2025 年，公共卫生支出预计将上升至 GDP 的 2.5%。除此之外，医疗机构和服务提供者正在增加对预防策略和技术的投资，以最大限度地减少 SSI 的发病率。这包括采用严格的规程、先进的消毒技术、手术器械的抗菌涂层以及在伤口敷料和缝线中使用高科技材料。例如，2023年12月，弗林德斯大学与中国研究人员合作开发了一种具有强大抗感染能力的新型银镓骨科植入物覆盖物。这种新材料可以透过喷涂的方式轻鬆、可控地应用于多种医疗设备上，以保护它们免受感染，同时提供抗发炎作用。此外，2023年10月，Sylke Inc.推出了由纯低过敏丝素蛋白製成的敷料SYLKE。 SYLKE 促进手术伤口癒合，减少可能导致疤痕不良的併发症和感染。 SYLKE 致力于透过消除导致感染和不良疤痕结果的医用黏合剂相关皮肤损伤来改变手术伤口护理。

研究和临床试验的进展

研究和临床试验的进展在推动手术部位感染控制市场成长方面发挥着至关重要的作用，它促进了创新产品的开发、加强了治疗策略，并改善了患者的治疗效果。例如，2024 年 2 月，致力于改善手术效果的生物製药公司 PolyPid Ltd. 在招募第 100 名患者后宣布其 SHIELD II 3 期临床研究取得了重大进展。这项研究检视了 D-PLEX100 的功效，D-PLEX100 是一种用于预防腹部结直肠手术中手术部位感染 (SSI) 的候选产品。 SHIELD II 试验的最终结果预计将于 2024 年下半年公布，届时约有 40 个地点积极参与研究。此外，研究和临床试验有助于确定手术环境中感染预防和控制的最佳实践和指南。关于术前准备、手术技术、抗菌预防和术后护理的实证建议有助于标准化方案并提高对感染控制措施的依从性，最终降低 SSI 的发生率并改善患者的预后。例如，2023 年 8 月，埃默里大学进行了一项研究，该研究涉及 20,000 多名患者，并使用自动化方法提供回馈和评估表现，发现抗生素预防依从性提高了 12%，整体 SSI 降低了 33%。外科感染学会 2023 年年会上公布的数据表明，独特的自动化抗生素预防方法可显着减少手术部位感染。这些因素进一步对手术部位感染控制市场预测产生了正面影响。

手术部位感染控制关键市场细分：

按产品分类：

  • 抗生素预防产品
  • 伤口护理敷料
  • 手术单
  • 手术钳
  • 防腐剂和消毒剂
  • 伤口冲洗产品
  • 其他的

抗生素预防产品目前在市场上占据明显主导地位

根据手术部位感染控制市场前景，抗生素预防在预防手术部位感染（SSI）方面发挥着至关重要的作用，而手术部位感染是医疗保健环境中的重要议题。通常在手术切口前不久使用抗生素，以便在潜在的细菌污染时达到足够的组织浓度。给药时间至关重要，理想情况下应在手术切口前 60 分钟内进行，但某些抗生素和手术可能有例外。此外，预防性抗生素治疗方案通常根据不同手术程序的特定要求进行客製化。例如，骨科手术可能需要金黄色葡萄球菌和链球菌的防护，而结直肠手术可能需要额外对革兰氏阴性菌和厌氧菌的防护。例如，2024年1月，美国创伤外科协会（AAST）、世界外科感染学会欧洲分会（SIS-E）、全球外科感染联盟（GAIS）和世界急诊外科协会（WSES）合作制定了涉及头部、脑、躯干、颚面部、四肢、皮肤和软组织的创伤性病变的抗生素预防（AP）重要指南。

按感染类型分类：

  • 表层切口SSI
  • 深切口SSI
  • 器官或空间 SSI

目前，浅层切口 SSI 占据全球大部分市场份额

根据手术部位感染市场概况，浅层切口手术部位感染 (SSI) 占所有 SSI 的很大一部分。这些感染发生在手术后 30 天内，仅涉及切口的皮肤和皮下组织。其通常特征是手术部位发红、发热、肿胀和局部疼痛等症状。它们是外科实务中最常见的 SSI 类型。它们的发生率相对较高，凸显了它们在感染控制工作中的重要性。例如，根据美国国家医学图书馆 2023 年发表的一篇文章，59% 的 SSI 患者患有表浅性 SSI。

依手术类型分类：

  • 剖腹产
  • 胃绕道手术
  • 白内障手术
  • 牙齿修復
  • 其他的

剖腹产目前占据最大的市场份额

剖腹产是全球最常见的外科手术之一。在许多国家，剖腹产率多年来一直稳定上升。由于剖腹产手术量如此之大，预防手术部位感染成为感染控制工作的重点。此外，剖腹产手术部位特别容易受到感染，因为它靠近生殖道和胃肠道，而这些部位含有大量细菌。此外，此手术会破坏皮肤和子宫壁的保护屏障，增加污染的风险。除此之外，剖腹产后的手术部位感染可能会对母亲和新生儿造成严重后果。除了引起不适和延长母亲的住院时间外，SSI 还会导致子宫内膜炎、伤口裂开、败血症等併发症，并增加医疗费用。病原体还存在垂直传播给新生儿的风险，从而导致新生儿感染。例如，根据世界卫生组织 (WHO) 的资料，剖腹产的使用正在增加，2021 年每五例分娩中就有一例以上 (21%) 是剖腹产。预计这一数字在未来十年将进一步上升，到 2030 年，所有分娩中将有近三分之一 (29%) 是剖腹产。

按最终用户分类：

  • 医院
  • 门诊手术中心
  • 其他的

目前，医院在市场上占据明显主导地位

医院对手术部位感染 (SSI) 控制的需求源于与病人安全、医疗品质、监管要求和财务考量相关的各种因素。预防手术部位感染对于确保患者安全和最大限度地降低术后併发症的风险至关重要。 SSI 可导致严重的发生率、延长住院时间、增加医疗费用，严重时甚至会导致死亡。医院有道德和伦理义务为病人提供安全和高品质的护理，其中包括实施控製手术部位感染的措施。此外，医院越来越注重提供高品质的护理并在社区内维护良好的声誉。预防 SSI 是医疗保健品质改进工作的一个基本面向。有效控制 SSI 的医院会被病人、医疗保健专业人员、保险公司和监管机构视为更安全、更可靠。

按地区划分：

  • 北美洲
  • 美国
  • 加拿大
  • 亚太
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他的
  • 中东和非洲

北美目前占据全球市场主导地位

市场研究报告也对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美目前占据全球市场主导地位。

根据手术部位感染控制市场统计，北美是全球最大的医疗保健产品和服务市场之一。在此背景下，SSI 控制市场涵盖了广泛的产品，包括抗菌剂、手术单、手套、消毒设备、伤口护理产品和监控系统。儘管手术技术和感染控制措施不断进步，但手术部位感染 (SSI) 仍然是北美医疗机构关注的重大议题。 SSI 的盛行率在不同的外科专业和环境中有所不同，但对医疗保健系统造成了巨大的临床和经济负担。例如，2021年2月，宾州大学医学院开设了新的介入支援中心（ISC），使其成为美国西南费城最着名的器械处理和手术用品准备设施之一。 ISC 是宾州首批此类设施之一，工作人员每天对数千件器械进行消毒和包装，为手术和程序做准备，从基本的剪刀和夹子到复杂的机器人器械。例如，根据美国国家医学图书馆发表的一篇文章，2024年2月，美国手术部位感染导致约200万例院内感染，这大大提高了术后发病率和死亡率。与此相符的是，根据麦克马斯特大学和马里兰大学医学院于 2024 年 2 月共同领导的国际试验，每年数千名接受闭合性骨折手术的患者可以透过使用酒精中的碘聚丙烯酰氯对皮肤进行消毒来避免手术部位感染。

（请注意，这只是关键参与者的部分列表，完整列表在报告中提供。）

手术部位感染控制市场最新发展：

2024 年 5 月：爱沙尼亚医疗技术公司 Nanordica Medical 获得 175 万欧元，以治疗严重伤口的一流伤口护理解决方案进入市场。

2024 年 4 月：Vomaris 推出了 PowerHeal，这是一种经 FDA 批准用于非处方 (OTC) 伤口管理的生物电绷带。

2024 年 2 月：致力于改善手术效果的生物製药公司 PolyPid Ltd. 在招募第 100 名患者后宣布其 SHIELD II 第 3 期临床研究取得了重大进展。这项研究检视了 D-PLEX100 的功效，D-PLEX100 是一种用于预防腹部结直肠手术中手术部位感染 (SSI) 的候选产品。

本报告回答的关键问题

  • 手术部位感染控制市场有多大
  • 2025-2033年全球手术部位感染控制市场的预期成长率是多少
  • 推动全球手术部位感染控制市场的关键因素有哪些
  • COVID-19 对全球手术部位感染控制市场有何影响
  • 根据产品，全球手术部位感染控制市场如何划分
  • 根据感染类型，全球手术部位感染控制市场如何划分
  • 根据手术类型，全球手术部位感染控制市场如何划分
  • 根据最终用户，全球手术部位感染控制市场如何划分
  • 全球手术部位感染控制市场的主要区域有哪些
  • 10. 全球手术部位感染控制市场的主要参与者/公司有哪些？

本报告回答的关键问题

  • 手术部位感染控制市场有多大？ 2025 年至 2033 年期间全球手术部位感染控制市场的预期成长率为何？
  • 推动全球手术部位感染控制市场发展的关键因素有哪些？
  • COVID-19 对全球手术部位感染控制市场有何影响？
  • 根据产品，全球手术部位感染控制市场是如何分布的？
  • 根据感染类型，全球手术部位感染控制市场是如何分布的？
  • 根据手术类型，全球手术部位感染控制市场是如何分布的？
  • 根据最终用户，全球手术部位感染控制市场是如何分布的？
  • 全球手术部位感染控制市场的关键区域有哪些？
  • 全球手术部位感染控制市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球手术部位感染控制市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 抗生素预防产品
  • 伤口护理敷料
  • 手术单
  • 手术钳
  • 防腐剂和消毒剂
  • 伤口冲洗产品
  • 其他的

第七章：市场区隔：依感染类型

  • 表层切口SSI
  • 深切口SSI
  • 器官或空间 SSI

第八章：市场区隔：依手术类型

  • 剖腹产
  • 胃绕道手术
  • 白内障手术
  • 牙齿修復
  • 其他的

第九章：市场区隔：依最终用户

  • 医院
  • 门诊手术中心
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • Ansell Limited
    • Becton Dickinson and Company
    • bioMerieux SA. (Institut Merieux)
    • Covalon Technologies Ltd.
    • GAMA Healthcare Ltd.
    • Getinge AB (Carl Bennet AB)
    • Johnson & Johnson
    • Kimberly-Clark Corporation
    • Molnlycke Health Care AB
    • Prescient Surgical
    • Steris Corporation
Product Code: SR112025A5669

The global surgical site infection control market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.59% during 2025-2033. The increasing surgical procedures, growing awareness about healthcare-associated infections, enhanced focus on patient safety, and surging healthcare expenditure are some of the major factors propelling the market growth.

Surgical Site Infection Control Market Analysis:

Major Market Drivers: The rising cases of hospital-acquired infections and the increasing prevalence of chronic conditions, such as cancer, gastrointestinal disorders, cardiovascular diseases (CVDs), etc., due to the aging population, sedentary lifestyles, and unhealthy eating habits are propelling the adoption of surgical site infection control. Moreover, several favorable initiatives undertaken by the governing and non-governing agencies of various countries, such as the introduction of stringent guidelines and training programs focused on infection control practices, are propelling the surgical site infection control market.

Key Market Trends: The increasing prevalence of surgical site infections, ongoing technological advancements in infection control products, rising adoption of minimally invasive surgeries, and introduction of stringent regulatory standards are expected to propel the surgical site infection control market demand. Moreover, with the rise in healthcare expenditure globally, there is a growing focus on improving patient outcomes and reducing healthcare-associated infections, including SSIs. This trend is expected to drive the demand for advanced infection control solutions in surgical settings.

Competitive Landscape: Some of the leading surgical site infection control market companies are 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Merieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Molnlycke Health Care AB, Prescient Surgical, and Steris Corporation, among many others.

Geographical Trends: According to the report, North America currently dominates the overall market. The region represents one of the largest markets for surgical site infection control products and services globally. The market size is influenced by factors such as the increase in the number of surgical procedures, advanced healthcare infrastructures, wide presence of regulatory landscape, ongoing technological innovations, etc. The market has been experiencing steady growth due to the increasing awareness about healthcare-associated infections and the importance of infection prevention measures.

Challenges and Opportunities: Antibiotic resistance, compliance issues, cost consideration, and variations in surgical practices and protocols across different healthcare facilities are some of the challenges that the market is facing. However, advances in medical technology, such as the development of antimicrobial coatings, novel surgical materials, and robotic-assisted surgery, offer the surgical site infection control market recent opportunities to enhance infection control in surgical settings.

Surgical Site Infection Control Market Trends:

Rising Geriatric Population

Many regions worldwide are experiencing a demographic shift characterized by a growing proportion of older adults aged 65 and above. For instance, according to the World Health Organization, by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up will rise from 1 billion in 2020 to 1.4 billion. By 2050, the global population of persons aged 60 and up will double (2.1 billion). The number of people aged 80 and older is anticipated to treble between 2020 and 2050, reaching 426 million. Older adults are more vulnerable to SSIs due to age-related changes in the immune system, reduced tissue healing capacity, and the presence of comorbidities such as diabetes, hypertension, and cardiovascular disease. As the geriatric population grows, there is a corresponding increase in the number of surgical procedures performed on older adults, leading to a higher demand for infection control measures to mitigate the risk of SSIs. For instance, according to an article published by the National Library of Medicine in March 2021, nearly 4 million surgical procedures were performed each year in older adults aged 65 years and above. In line with this, according to another article published by the National Library of Medicine in March 2023, in total knee replacement surgery, the SSI rates were higher in older adults aged 76-80 years when compared with the age group of 61-65 years. These factors are further bolstering the surgical site infection market revenue.

Increasing Surgical Procedure and Healthcare Infrastructure Development

There has been a significant increase in surgical procedures across the world. For instance, according to an article published by the National Library of Medicine, in September 2020, 11% of the world's illness burden necessitates surgical intervention, anesthetic management, or both. The most common procedures were for cataracts (22.8%), Caesareans (3.8%), fracture surgeries (3.27%), and hernias (2.86%). The necessary operations made up 44.2% of all surgeries. Moreover, healthcare infrastructure development initiatives, particularly in emerging markets, contribute to the growth of the surgical site infection control market. According to an article published by the India Investment Grid, public health expenditure is expected to rise to 2.5% of GDP by 2025. Apart from this, healthcare facilities and providers are increasingly investing in preventive strategies and technologies to minimize the incidence of SSIs. This includes the adoption of stringent protocols, advanced sterilization techniques, antimicrobial coatings for surgical instruments, and the utilization of high-tech materials in wound dressings and sutures. For instance, in December 2023, Flinders University and Chinese researchers collaborated to develop a new Ag-Ga orthopedic implant covering that is highly resistant to infection. The novel material could be readily and controllably put by spray-casting on numerous medical devices to protect them from infection while simultaneously providing an anti-inflammatory impact. Moreover, in October 2023, Sylke Inc. introduced SYLKE, the dressing manufactured from pure hypoallergenic silk fibroin. SYLKE promotes healing in surgical wounds and reduces complications and infections that might cause poor scarring. SYLKE seeks to transform surgical wound care by removing medical adhesive-related skin damage that causes infections and poor scarring outcomes.

Advances in Research Studies and Clinical Trials

Advances in research studies and clinical trials play a crucial role in driving growth in the surgical site infection control market by facilitating the development of innovative products, enhancing treatment strategies, and improving patient outcomes. For instance, in February 2024, PolyPid Ltd., a biopharmaceutical company dedicated to improving surgical outcomes, announced considerable progress in its SHIELD II Phase 3 clinical study, after enrolling its 100th patient. This research looked at the efficacy of D-PLEX100, a product candidate intended to prevent surgical site infections (SSIs) in abdominal colorectal procedures. Top-line results from the SHIELD II trial were expected in the second half of 2024, with about 40 locations actively participating in the study. Moreover, research studies and clinical trials contribute to the identification of best practices and guidelines for infection prevention and control in surgical settings. Evidence-based recommendations regarding preoperative preparation, surgical techniques, antimicrobial prophylaxis, and postoperative care help standardize protocols and improve adherence to infection control measures, ultimately reducing the incidence of SSIs and improving patient outcomes. For instance, in August 2023, Emory University performed research which included over 20,000 patients and used automated methods to provide feedback and evaluate performance, found a 12% increase in antibiotic prophylactic compliance and a 33% decrease in overall SSIs. Data presented at the Surgical Infection Society's 2023 annual meeting showed that a unique automated antibiotic prophylaxis approach significantly reduces surgical site infections. These factors are further positively influencing the surgical site infection control market forecast.

Surgical Site Infection Control Key Market Segmentation:

Breakup by Product:

  • Antibiotic Prophylaxis Products
  • Wound Care Dressings
  • Surgical Drapes
  • Surgical Clippers
  • Antiseptics and Disinfectants
  • Wound Irrigation Products
  • Others

Antibiotic prophylaxis products currently exhibit a clear dominance in the market

According to the surgical site infection control market outlook, antibiotic prophylaxis plays a crucial role in preventing surgical site infections (SSIs), which are a significant concern in healthcare settings. Antibiotics are usually administered shortly before surgical incision to achieve adequate tissue concentrations at the time of potential bacterial contamination. The timing of administration is critical and should ideally occur within 60 minutes before the surgical incision, although exceptions may exist for certain antibiotics and procedures. Moreover, prophylactic antibiotic regimens are often tailored to the specific requirements of different surgical procedures. For example, orthopedic surgeries may require coverage against Staphylococcus aureus and streptococci, while colorectal surgeries may necessitate additional coverage against gram-negative and anaerobic bacteria. For instance, in January 2024, the American Association for the Surgery of Trauma (AAST), the World Surgical Infection Society Europe (SIS-E), the Global Alliance for Infection in Surgery (GAIS), and the World Society of Emergency Surgery (WSES) collaborated to develop important guidelines for antibiotic prophylaxis (AP) in cases of traumatic lesions involving the head, brain, torso, maxillofacial region, extremities, skin, and soft tissues.

Breakup by Infection Type:

  • Superficial Incisional SSI
  • Deep Incisional SSI
  • Organ or Space SSI

Currently, superficial incisional SSI accounts for the majority of the global market share

According to the surgical site infection market overview, superficial incisional surgical site infections (SSIs) represent a significant portion of all SSIs. These infections occur within 30 days after the operation and involve only the skin and subcutaneous tissue of the incision. They are often characterized by symptoms such as redness, warmth, swelling, and localized pain at the surgical site. They are among the most common types of SSIs encountered in surgical practice. Their relatively high incidence underscores their importance in infection control efforts. For instance, according to an article published by the National Library of Medicine in 2023, 59% of the total SSI patients had superficial SSI.

Breakup by Surgery Type:

  • Cesarean Section
  • Gastric Bypass
  • Cataract Surgery
  • Dental Restoration
  • Others

Cesarean section currently holds the largest market share

Cesarean sections are one of the most common surgical procedures globally. In many countries, the rates of C-section deliveries have been increasing steadily over the years. With such a high volume of procedures, the prevention of SSIs in C-sections becomes a significant focus of infection control efforts. Moreover, the surgical site in a Cesarean section is particularly vulnerable to infection due to its proximity to the genital and gastrointestinal tracts, which harbor numerous bacteria. Additionally, the procedure involves breaching the protective barriers of the skin and uterine wall, increasing the risk of contamination. Apart from this, SSIs following Cesarean sections can have serious consequences for both the mother and the newborn. In addition to causing discomfort and prolonging hospital stays for the mother, SSIs can lead to complications such as endometritis, wound dehiscence, sepsis, and increased healthcare costs. There's also a risk of vertical transmission of pathogens to the newborn, which can result in neonatal infections. For instance, according to World Health Organization (WHO) data, the use of cesarean sections is increasing, accounting for more than one in every five (21%) childbirths in 2021. This figure is expected to rise further over the next decade, with almost one-third (29%) of all births by cesarean section by 2030.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Currently, hospitals exhibit a clear dominance in the market

The demand for surgical site infection (SSI) control in hospitals arises from various factors related to patient safety, healthcare quality, regulatory requirements, and financial considerations. Preventing SSIs is essential for ensuring patient safety and minimizing the risk of postoperative complications. SSIs can lead to significant morbidity, prolonged hospital stays, increased healthcare costs, and in severe cases, mortality. Hospitals have a moral and ethical obligation to provide safe and high-quality care to their patients, which includes implementing measures to control SSIs. Moreover, hospitals are increasingly focused on delivering high-quality care and maintaining a positive reputation within their communities. Preventing SSIs is a fundamental aspect of healthcare quality improvement efforts. Hospitals that effectively control SSIs are perceived as safer and more reliable by patients, healthcare professionals, insurers, and regulatory agencies.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America currently dominates the global market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.

According to the surgical site infection control market statistics, North America represents one of the largest markets for healthcare products and services globally. Within this context, the SSI control market encompasses a wide range of products, including antimicrobial agents, surgical drapes, gloves, sterilization equipment, wound care products, and surveillance systems. Despite advances in surgical techniques and infection control practices, SSIs remain a significant concern in North American healthcare facilities. The prevalence of SSIs varies across different surgical specialties and settings but represents a substantial clinical and economic burden on healthcare systems. For instance, in February 2021, Penn Medicine opened its new Interventional Support Center (ISC), making it one of the most prominent instrument processing and surgical supply preparation facilities in Southwest Philadelphia, United States. The ISC is one of Pennsylvania's first facilities of its sort, with staff sterilizing and packaging thousands of instruments daily in preparation for surgeries and procedures, ranging from basic scissors and clamps to complex robotic instruments. For instance, according to an article published by the National Library of Medicine, in February 2024, surgical site infections accounted for approximately two million nosocomial infections in the U.S., which considerably raises postoperative morbidity and mortality rates. In line with this, according to the international trial co-led by McMaster University and the University of Maryland School of Medicine in February 2024, thousands of patients yearly undergoing surgery for a closed fracture may avoid surgical site infections by using iodine povacrylex in alcohol to disinfect their skin.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players that are mentioned below:

  • 3M Company
  • Ansell Limited
  • Becton Dickinson and Company
  • bioMerieux SA. (Institut Merieux)
  • Covalon Technologies Ltd.
  • GAMA Healthcare Ltd.
  • Getinge AB (Carl Bennet AB)
  • Johnson & Johnson
  • Kimberly-Clark Corporation
  • Molnlycke Health Care AB
  • Prescient Surgical
  • Steris Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Surgical Site Infection Control Market Recent Developments:

May 2024: Nanordica Medical, an Estonian medical technology firm, received €1.75 million to enter the market with first-in-class wound care solutions that treat serious wounds.

April 2024: Vomaris launched PowerHeal, a bioelectric bandage approved by the FDA for over-the-counter (OTC) use in the management of wounds.

February 2024: PolyPid Ltd., a biopharmaceutical company dedicated to improving surgical outcomes, announced considerable progress in its SHIELD II Phase 3 clinical study, after enrolling its 100th patient. This research looked at the efficacy of D-PLEX100, a product candidate intended to prevent surgical site infections (SSIs) in abdominal colorectal procedures.

Key Questions Answered in This Report

  • 1.How big is the surgical site infection control market?
  • 2.What is the expected growth rate of the global surgical site infection control market during 2025-2033?
  • 3.What are the key factors driving the global surgical site infection control market?
  • 4.What has been the impact of COVID-19 on the global surgical site infection control market?
  • 5.What is the breakup of the global surgical site infection control market based on the product?
  • 6.What is the breakup of the global surgical site infection control market based on the infection type?
  • 7.What is the breakup of the global surgical site infection control market based on the surgery type?
  • 8.What is the breakup of the global surgical site infection control market based on the end user?
  • 9.What are the key regions in the global surgical site infection control market?
  • 10.Who are the key players/companies in the global surgical site infection control market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Surgical Site Infection Control Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibiotic Prophylaxis Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Wound Care Dressings
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Surgical Drapes
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Surgical Clippers
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Antiseptics and Disinfectants
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Wound Irrigation Products
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Infection Type

  • 7.1 Superficial Incisional SSI
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Deep Incisional SSI
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Organ or Space SSI
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Surgery Type

  • 8.1 Cesarean Section
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Gastric Bypass
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cataract Surgery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Dental Restoration
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 3M Company
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Ansell Limited
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 bioMerieux SA. (Institut Merieux)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Covalon Technologies Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 GAMA Healthcare Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Getinge AB (Carl Bennet AB)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Kimberly-Clark Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Molnlycke Health Care AB
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 SWOT Analysis
    • 15.3.11 Prescient Surgical
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Steris Corporation
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Surgical Site Infection Control Market: Major Drivers and Challenges
  • Figure 2: Global: Surgical Site Infection Control Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Surgical Site Infection Control Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Surgical Site Infection Control Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Surgical Site Infection Control Market: Breakup by Infection Type (in %), 2024
  • Figure 6: Global: Surgical Site Infection Control Market: Breakup by Surgery Type (in %), 2024
  • Figure 7: Global: Surgical Site Infection Control Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Surgical Site Infection Control Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Surgical Site Infection Control (Antibiotic Prophylaxis Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Surgical Site Infection Control (Antibiotic Prophylaxis Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Surgical Site Infection Control (Wound Care Dressings) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Surgical Site Infection Control (Wound Care Dressings) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Surgical Site Infection Control (Surgical Drapes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Surgical Site Infection Control (Surgical Drapes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Surgical Site Infection Control (Surgical Clippers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Surgical Site Infection Control (Surgical Clippers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Surgical Site Infection Control (Antiseptics and Disinfectants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Surgical Site Infection Control (Antiseptics and Disinfectants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Surgical Site Infection Control (Wound Irrigation Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Surgical Site Infection Control (Wound Irrigation Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Surgical Site Infection Control (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Surgical Site Infection Control (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Surgical Site Infection Control (Superficial Incisional SSI) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Surgical Site Infection Control (Superficial Incisional SSI) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Surgical Site Infection Control (Deep Incisional SSI) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Surgical Site Infection Control (Deep Incisional SSI) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Surgical Site Infection Control (Organ or Space SSI) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Surgical Site Infection Control (Organ or Space SSI) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Surgical Site Infection Control (Cesarean Section) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Surgical Site Infection Control (Cesarean Section) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Surgical Site Infection Control (Gastric Bypass) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Surgical Site Infection Control (Gastric Bypass) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Surgical Site Infection Control (Cataract Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Surgical Site Infection Control (Cataract Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Surgical Site Infection Control (Dental Restoration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Surgical Site Infection Control (Dental Restoration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Surgical Site Infection Control (Other Surgery Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Surgical Site Infection Control (Other Surgery Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Surgical Site Infection Control (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Surgical Site Infection Control (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Surgical Site Infection Control (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Surgical Site Infection Control (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Surgical Site Infection Control (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Surgical Site Infection Control (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: North America: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: North America: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: United States: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: United States: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Canada: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Canada: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Asia-Pacific: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Asia-Pacific: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: China: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: China: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Japan: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Japan: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: India: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: India: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: South Korea: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: South Korea: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Australia: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Australia: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Indonesia: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Indonesia: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Europe: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Europe: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Germany: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Germany: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: France: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: France: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: United Kingdom: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: United Kingdom: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Italy: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Italy: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Spain: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Spain: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Russia: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Russia: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Latin America: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Latin America: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Brazil: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Brazil: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Mexico: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Mexico: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Others: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Middle East and Africa: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Middle East and Africa: Surgical Site Infection Control Market: Breakup by Country (in %), 2024
  • Figure 93: Middle East and Africa: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Global: Surgical Site Infection Control Industry: SWOT Analysis
  • Figure 95: Global: Surgical Site Infection Control Industry: Value Chain Analysis
  • Figure 96: Global: Surgical Site Infection Control Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Surgical Site Infection Control Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Surgical Site Infection Control Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Surgical Site Infection Control Market Forecast: Breakup by Infection Type (in Million USD), 2025-2033
  • Table 4: Global: Surgical Site Infection Control Market Forecast: Breakup by Surgery Type (in Million USD), 2025-2033
  • Table 5: Global: Surgical Site Infection Control Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Surgical Site Infection Control Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Surgical Site Infection Control Market: Competitive Structure
  • Table 8: Global: Surgical Site Infection Control Market: Key Players